Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8664210
SERIAL NO

12680988

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

New aminooxime derivatives at position 3 of 2- and/or 4-substituted androstanes and androstenes, processes for their preparation, and to pharmaceutical compositions containing them for the treatment of cardiovascular disorders, such as heart failure and hypertension. In particular compounds having the general formula (I) are described, where the radicals have the meanings described in detail in the application.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S P A00144 ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bianchi, Giuseppe Milan, IT 57 350
Cabri, Walter Rozzano, IT 98 224
Cerri, Alberto Milan, IT 25 41
Fedrizzi, Giorgio Treviglio, IT 3 3
Ferrari, Patrizia Varese, IT 33 60
Gobbini, Mauro Mercallo, IT 17 43
Marazzi, Giuseppe Milan, IT 5 6
Torri, Marco Rho, IT 9 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 4, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00